about
Influence of mast cells in drug-induced gingival overgrowthA mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1Cyclosporine A: Novel concepts in its role in drug-induced gingival overgrowthGingival fibromatosis: clinical, molecular and therapeutic issuesLevels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine AMechanism of drug-induced gingival overgrowth revisited: a unifying hypothesisDown-regulation of transforming growth factor beta-2 expression is associated with the reduction of cyclosporin induced gingival overgrowth in rats treated with roxithromycin: an experimental studyPhenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts.Conservative management of amlodipine influenced gingival enlargement.The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts.A clinical review of drug-induced gingival overgrowths.Dental plaque-induced gingival diseases.Cyclosporine A-induced gingival hyperplasia pemphigus vulgaris: literature review and report of a case.Hereditary gingival fibromatosis.Diagnosis and management of periodontal diseases in children and adolescents.Recurrent idiopathic gingival enlargement in an olive baboon (Papio anubis).Analysis of proliferative activity in oral gingival epithelium in immunosuppressive medication induced gingival overgrowth.Management of amlodipine-induced gingival enlargement: Series of three cases.Untypical amlodipine-induced gingival hyperplasia.Loss of basement membrane integrity in human gingival overgrowthClinical assessment of nifedipine-induced gingival overgrowth in a group of brazilian patients.Calcium antagonists and deep gingival pockets in the population-based SHIP study.Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review.Sodium valproate induced gingival enlargement with pre-existing chronic periodontitisUsing Salivary Nitrite and Nitrate Levels as a Biomarker for Drug-Induced Gingival Overgrowth.Hereditary gingival fibromatosis: characteristics and novel putative pathogenic mechanisms.Drug-induced gingival overgrowth: The nemesis of gingiva unravelled.Proliferative and inductive effects of Cyclosporine a on gingival fibroblast of child and adult.Is there a relationship between periodontal conditions and number of medications among the elderly?Homeostatic role of transforming growth factor-beta in the oral cavity and esophagus of mice and its expression by mast cells in these tissues.Assessing Systems of Care for US Children with Epilepsy/Seizure Disorder.Cyclosporine-induced gingival overgrowth in New Zealand White rabbits (Oryctolagus cuniculus).Medical disorders and orthodontics.Destructive membranous periodontal disease (ligneous gingivitis): a literature review.Application of evidence-based dentistry: from research to clinical periodontal practice.A rare case report of amlodipine-induced gingival enlargement and review of its pathogenesis.Successful management of phenytoin and phenobarbitone induced gingival enlargement: A multimodal approach.Common periodontal diseases of children and adolescents.Drug-Mediated Regulation of Glycosaminoglycan Biosynthesis.Interdisciplinary management of a patient with a drug-induced gingival hyperplasia.
P2860
Q21285095-4106CDD2-7692-420F-8D8B-F96EAEA8D80AQ24613504-CF6EA6AE-EBD0-4767-8D2A-21D064F20B07Q26772184-0585D21B-93D1-4C45-B246-F8C8A1875D0CQ28067236-EE35DBFB-9B8B-4F22-934B-A2EA2749F298Q28371932-3012F35C-455D-4106-9A32-CC6F7B99F592Q28468537-A4FFFFDE-DAB6-48C1-BB72-B34FE1DB7D2CQ30967183-B13A8241-C145-442D-A406-3E4BA8A26177Q31417108-0F3D1413-3711-49D4-AB6A-C4E30F9874D7Q33757863-0DEBE38F-D8AB-4A5C-83BC-C7854024D8A8Q33768650-3C7A68E1-4846-4028-9E0F-5F70F00ED74CQ33844744-E57954D7-BD6E-4999-812A-29D6C265089DQ33906599-75ED3B85-454F-49A5-AA09-AB96F6E7DC25Q33916257-732F4A1E-C756-4908-A662-9FEAB3869511Q34259581-60907FDE-F69F-454D-938B-3352218B2D8CQ34308311-1A64149B-1C47-4B01-BFE7-4690C186B482Q34362513-908AB205-0F93-4B2F-B473-4D73DB109FACQ34972913-BD45495C-2AC4-4C47-98FC-EB463431AFA2Q35053863-A836E9D0-3035-4D44-B14C-0EBB68616A8AQ35065601-7D0DBD59-4E4A-4B46-9296-BE6D9776E209Q35140527-D59AD187-4D94-4D4B-A7A4-2201B036ED3AQ35269928-8C570108-4E1B-479D-96D0-327920684ED0Q35827227-A83F4A6D-8A9C-4527-9AF0-CC09DB4EAB80Q36097981-D3E41774-6255-4060-9CE8-9A52CB2206B7Q36283511-06E9F9FC-928D-4930-89EE-C7D8B0041635Q36332814-C49F7054-4F34-4B87-BEA2-A9FC5C4ACC53Q36692626-DCD5FE43-2F9E-4662-A65A-C7C80FDBE9BDQ37020252-FE85C961-6F18-42CE-BFAC-FCA02857FDE3Q37023263-66165A16-6DD1-4769-B385-B0E04A5B1765Q37196571-CAE8F7EE-4ABF-49A8-ABCA-5695B568DEACQ37197348-1037F31E-0798-419B-A05E-AD305AB4E093Q37283488-5729A46A-48C5-4115-BAB1-441F76AFB565Q37425537-917A21B0-8471-4DC0-A512-FB0EB989EB7BQ37637684-3410E254-C09B-46C1-AAD6-7ADA30E9B53FQ37920906-06332262-65E9-4E0E-837E-40EDF9D2DCBEQ38002939-F13F3761-7A9D-4EEA-B5C7-5544F1EFBA97Q38136212-BCEEE06F-06FD-4CD0-A362-93A78D58BE87Q38223092-581BF55B-50F3-4F5D-A28A-6AFDFD50FDA6Q38233037-5E8FD0B7-3198-48A0-96CE-01E937658037Q39060517-303A1C08-603D-499B-975B-F4CB34281709Q39226781-0B0BFF31-C6FF-43B7-AEBF-287CE83057B7
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The pathogenesis of drug-induced gingival overgrowth.
@en
type
label
The pathogenesis of drug-induced gingival overgrowth.
@en
prefLabel
The pathogenesis of drug-induced gingival overgrowth.
@en
P2093
P1476
The pathogenesis of drug-induced gingival overgrowth.
@en
P2093
P304
P356
10.1111/J.1600-051X.1996.TB02072.X
P407
P433
P577
1996-03-01T00:00:00Z